Current Concepts in the Multidisciplinary Management of Colorectal Cancer
CME Course at The Sidney Kimmel Cancer Center at Johns Hopkins
March 20, 2009
Click on each title to view & listen to the presentations
Francis M. Giardiello, M.D
Update on Epidemiology and Screening in Colorectal Cancer
Bert Vogelstein, MD Cancer Genomes & Their Implications
Michael A. Choti, M.D.
Chemotherapy Use for Resectable Hepatic Metastases: Before or After?
Nita Ajuha, M.D. Management of Rare Tumors: Carcinoids and Appendiceal Cancers
Luis Diaz, M.D.
Adjuvant Treatment for Stage II/III Colon Cancer
Dan Laheru, M.D.
Systemic Therapy for Metastatic Colon Cancer: Sorting Through the Options
Timothy M. Pawlik, M.D., M.P.H.
Cytoreductive Surgery IPHC For Patients with Carcinomatosis from CRC
Susan Gearhart, M.D.
Early Rectal Cancer: Current Management
Joseph Herman, M.D., M.Sc.
Neoadjuvant Chemoradiation for Rectal Cancer: Is More Better?
Michael R. Marohn
Laparoscopic Resection for Colorectal Cancer: Is it Really Better?
Kenzo Hirose, M.D.
Evolvinig Role for Surgery in Metastatic Colorectal Cancer
Colorectal cancer is one of the most common types of cancer in the United States. It is the third most common type of cancer and the second leading cause of cancer-related death in the Western world. Colorectal cancer causes 655,000 deaths worldwide per year. In 2008, there had been an estimated 108,070 new cases of colon cancer and 40,740 new cases of rectal cancer, with 49,960 deaths due to colon and rectal cancer combined. It is, however, one of the most potentially curable of gastrointestinal cancers. Screening is vital to prevention and should be a part of routine care for adults over the age of 50 who are at average risk. High-risk individuals (those with previous colon and/or rectal cancer, family history of colon and/or rectal cancer, inflammatory bowel disease, or history of colorectal polyps) require careful follow-up and, if necessary, screening prior to the age of 50. There have been many new discoveries in this disease in recent years and management options have evolved significantly. This course will focus solely on colorectal cancer and will address important current concepts in the multidisciplinary management of the disease. It has been carefully organized to foster interaction between faculty and participants and will provide a venue for discussion so that physicians are able to diagnose and treat their patients more effectively when returning to their practice.
After attending this activity participants will demonstrate the ability to:
• Summarize current trends in screening and prevention
• Describe the management of a high-risk patient
• Define surgical therapy of primary disease
• Differentiate between the different types of adjuvant therapy
• Identify recent advances in chemotherapy
• Discuss management of hepatic metastases
• Distinguish between the various stages of colorectal cancer and the different types of follow-up
• Describe palliation and end-of-life management for the colorectal cancer patient.